Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Top Cited Papers
- 15 June 2009
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 75 (12), 4053-4057
- https://doi.org/10.1128/aem.00231-09
Abstract
We reported the emergence of resistance to medical triazoles of Aspergillus fumigatus isolates from patients with invasive aspergillosis. A dominant resistance mechanism was found, and we hypothesized that azole resistance might develop through azole exposure in the environment rather than in azole-treated patients. We investigated if A. fumigatus isolates resistant to medical triazoles are present in our environment by sampling the hospital indoor environment and soil from the outdoor environment. Antifungal susceptibility, resistance mechanisms, and genetic relatedness were compared with those of azole-resistant clinical isolates collected in a previous study. Itraconazole-resistant A. fumigatus (five isolates) was cultured from the indoor hospital environment as well as from soil obtained from flower beds in proximity to the hospital (six isolates) but never from natural soil. Additional samples of commercial compost, leaves, and seeds obtained from a garden center and a plant nursery were also positive (four isolates). Cross-resistance was observed for voriconazole, posaconazole, and the azole fungicides metconazole and tebuconazole. Molecular analysis showed the presence of the dominant resistance mechanism, which was identical to that found in clinical isolates, in 13 of 15 environmental isolates, and it showed that environmental and clinical isolates were genetically clustered apart from nonresistant isolates. Patients with azole-resistant aspergillosis might have been colonized with azole-resistant isolates from the environment.This publication has 24 references indexed in Scilit:
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance MechanismPLoS Medicine, 2008
- Treatment of a Clinically Relevant Plant-Pathogenic Fungus with an Agricultural Azole Causes Cross-Resistance to Medical Azoles and Potentiates Caspofungin EfficacyAntimicrobial Agents and Chemotherapy, 2007
- Characterization of a Novel Gene for Strain Typing Reveals Substructuring of Aspergillus fumigatus across North AmericaEukaryotic Cell, 2007
- New taxa of Neosartorya and Aspergillus in Aspergillus section FumigatiAntonie van Leeuwenhoek, 2007
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 2007
- Multiple-Triazole–Resistant AspergillosisThe New England Journal of Medicine, 2007
- Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph NeosartoryaStudies in Mycology, 2007
- Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus IsolatesJournal of Clinical Microbiology, 2005
- Occurrence of dicarboximidic fungicides and their metabolites? residues in commercial compostAgronomy for Sustainable Development, 2004
- Factors affecting degradation rates of five triazole fungicides in two soil types: 2. Field studiesPesticide Science, 1999